Nonsurgical Treatment of Severe Hypertension Due to Renal-Artery Intimal Fibroplasia by Percutaneous Transluminal Angioplasty

Abstract

RENAL vascular surgery and pharmacotherapy are the are the two modalities currently employed, singly or in combination, in the management of renovascular hypertension.^{1 2 3} Although both methods have been used successfully in the treatment of this disorder, both have substantial drawbacks. Renovascular operations carry a consequential operative risk, have a substantial failure rate and are expensive.^{1 2 3 4 5 6} Furthermore, the suitability of this method of treating renovascular disease is clearly limited by the usually progressive and frequently bilateral nature of the dis-, order.^{1 , 2} On the other hand, pharmacotherapy of renovascular hypertension has such disadvantages as poor compliance, drug side effects and a sizable . . .